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Chronic functional somatic symptoms: 
a single syndrome?
Tim C olde Hartman, Peter L B J Lucassen, Eloy H van de Lisdonk, Hans H J Bor and Chris van Weel 
Introduction
MEDICALLY unexplained symptoms are common, andaccount for one in five new consultations in primary
care.1,2 In 25–50% of all primary care visits, no serious med-
ical (that is, organic) cause is found to explain the patient’s
presenting symptom, and 20–40% of the patients seen by
medical specialists do not receive a clear diagnosis.3,4 The
presented symptoms are then referred to as ‘medically
unexplained’ or ‘functional’.5 Functional, or rather medically
unexplained, somatic symptoms are ranked second on the
list of the 10 most common physical symptoms in primary
care and have an incidence rate of 70 per 1000 patient years
in the Netherlands.6
Although an occasional visit to the general practitioner
(GP) for a functional somatic symptom seems natural,
repeated consultations because of these symptoms rep-
resent a serious problem. Patients who do this are often
diagnosed as having ‘chronic functional somatic symp-
toms’. Psychological distress or psychosocial problems are
presumed to be the underlying causes.7 As such, diagnos-
ing chronic functional somatic symptoms requires the
patient to repeatedly present physical symptoms that remain
medically unexplained after adequate examination, and 
indications from the patient’s personal circumstances of pre-
sumed psychosocial problems or psychological distress.
When experiencing functional somatic symptoms seems to
have become a regular way of presenting, a patient is regis-
tered as having chronic functional somatic symptoms. 
As patients with chronic functional somatic symptoms
are functionally impaired, have high rates of comorbid
psychiatric disorders, and are at risk of unnecessary diag-
nostic procedures and treatments,1,4,8-11 a correct diagnosis
is of paramount importance. However, most research on
this topic has been performed either on unselected popu-
lation-based samples,12,13 or in selected patients referred
to secondary care.14,15 Moreover, most of these studies
make use of questionnaires in which patients have to
recall a variety of symptoms existing for a considerable
amount of time.10,16,17 This method has been shown to
produce unstable results in which lifetime symptoms pre-
sent at baseline are not remembered at follow-up.18
Research on patients from primary care settings in whom
the diagnosis had been made on reliable longitudinal data
is generally lacking. 
Moreover, there is considerable debate regarding the
question of whether functional somatic symptoms cluster in
well defined distinct syndromes, such as fibromyalgia,
chronic fatigue syndrome, or tension headache, or whether
these specific somatic syndromes are largely an artefact of
medical specilisation.7,19 In this debate reliable data on pri-
mary care patients are also needed, whereas most research
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SUMMARY
Background: Reliable longitudinal data of patients with
functional somatic symptoms in general practice are lacking.
Aims: To identify distinctive features in patients with chronic
functional somatic symptoms, and to determine whether these
symptoms support the hypothesis of the existence of specific
somatic syndromes.
Design of study: Observational study, with a comparison
control group.
Setting: Four primary care practices affiliated with the
University of Nijmegen in the Netherlands.
Method: One hundred and eighty-two patients diagnosed
between 1998 and 2002 as having chronic functional somatic
symptoms and 182 controls matched by age, sex, socioeconomic
status, and practice were included. Data on comorbidity,
referrals, diagnostic tests, and hospital admissions over a period
of 10 years prior to the diagnosis were collected. Medication use
and number of visits to the general practitioner (GP) were
extracted from the moment computerised registration was
started.
Results: In the 10 years before the diagnosis of chronic
functional somatic symptoms, significantly more patients than
controls presented functional somatic symptoms in at least two
body systems, and used more somatic and psychotropic drugs.
They visited the GP twice as much, statistically had significantly
more psychiatric morbidity, and were referred more often to
mental health workers and somatic specialists. The number of
patients undergoing diagnostic tests was higher for patients
with chronic functional somatic symptoms than for controls, but
hospital admissions rates were equal.
Conclusion: Patients with chronic functional somatic symptoms
have a great diversity of functional somatic symptoms. They use
more somatic and psychotropic drugs than controls in the years
before diagnosis. Moreover, they show high rates of referrals
and psychiatric morbidity. The diversity of symptoms of patients
with chronic functional somatic symptoms supports the concept
that symptoms do not cluster in well defined distinct syndromes.
Therefore, patients with chronic functional somatic symptoms
should preferably not be classified into medical subspecialty
syndromes.
Keywords: somatoform disorders; psychophysiologic disorders;
family practice; referral and consultation; comorbidity.
 
on this topic is performed in referred populations20,21 con-
centrating on specific symptoms,22-24 or in community sam-
ples25 using questionnaires in which inconsistencies of
recall may have a great effect on the assessment of the 
ultimate diagnosis.18,26
The aims of this study, therefore, are to explore with 
longitudinal data:
• how and how often patients with chronic functional
somatic symptoms present to their GP and other
medical institutions,
• whether patients with chronic functional somatic
symptoms indeed present more functional somatic
symptoms in the years before the diagnosis,
• if symptoms presented by patients with chronic func-
tional somatic symptoms support the existence of
specific somatic syndromes.
Method
Continuous Morbidity Registration database
This study uses data from the Continuous Morbidity
Registration (CMR) database, a project of the Department
of Family Medicine of the University of Nijmegen in the
Netherlands.27-30 This project was started in 1971 in four
practices in and around Nijmegen31 and monitors a pop-
ulation of approximately 12 000 patients, representative of
the Dutch population with regard to age and sex. Every
episode of illness seen by, or reported to, the GP is regis-
tered as soon as it is established using an adapted version
of the E-list.32 Diagnoses and codes are corrected when
necessary. Over many years, monthly meetings of all GPs
involved are held to discuss classification problems, to
monitor the application of diagnostic criteria, and to dis-
cuss coding problems of hypothetical case histories. As
well as medical data, the following information is available:
age, sex, socioeconomic status (low, middle and high),
and marital status. In the beginning the registration 
was performed on the medical chart; since 1994 a 
computerised registration has been used. 
Patients with chronic functional somatic 
symptoms
We selected all patients from the CMR database in whom
chronic functional somatic symptoms were diagnosed for
the first time between 1998 and 2002 (n = 182). For a per-
iod of 10 years before this diagnosis, the following variables
had been collected: sociodemographic characteristics;
morbidity data; and data on referrals, diagnostic tests, and
hospital admissions. Use of medical facilities was assessed
by the number of contacts with the GP. Data on medication
use could be extracted from when computerised regist-
ration started, and medication data were transformed into
the prescribed daily dose by using the Anatomical
Therapeutical Chemical Classification/Defined Daily Doses
(ATC/DDD) system.33 As a proxy of somatic morbidity, we
assessed three prevalent categories of chronic disorders
(diabetes mellitus, asthma/chronic obstructive pulmonary
disease [COPD], and cardiovascular diseases) and three
prevalent categories of self-limiting disorders (skin, musc-
uloskeletal, and airway) in order to study the hypothesis
that patients with chronic functional somatic symptoms are
at risk of somatic morbidity.37
We allocated the registered functional somatic symptoms
to specific body systems; for example, gastrointestinal or
musculoskeletal, as described by Escobar et al.10 Irritable
bowel syndrome and hyperventilation syndrome, some-
times regarded as medically unexplained symptoms, are
not included in this study.
Controls
For each patient with chronic functional symptoms, a control
matched by age, sex, socioeconomic status, and practice was
drawn from the CMR population. The only exclusion criterion
in the control group was the diagnosis of chronic functional
somatic symptoms. Patients who were controls had to have
had at least one registered episode of illness during the per-
iod they had been on the practice list. For controls, the same
information as described for patients with chronic functional
somatic symptoms was obtained from 1990–2000.
Statistical methods
Our analysis primarily involved comparing patients with
chronic functional somatic symptoms with their matched
controls. Statistical analyses were conducted using SPSS
9.0. Descriptive statistics were calculated for all variables.
The data on specific body systems were analysed using
exploratory factor analysis, and then simplified by varimax
rotation. The χ2 test and student’s t-test were used for com-
paring means of consultations and medication use in both
groups. Odds ratios (ORs) and 95% confidence intervals
(CIs) were used as the main measurement for assoc-
iations, particularly with regard to functional somatic symp-
toms, comorbidity, referrals, diagnostic tests, and hospital
admissions. All P-values are two-tailed. 
Results
Characteristics of subjects
Of the 182 patients with chronic functional somatic symp-
toms included in the study, 141 (77.5%) were women; the
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HOW THIS FITS IN
What do we know?
For some 25–50% of patients accessing 
primary care, no serious medical reason can 
be given to explain their presenting symptoms. Patients with
chronic functional somatic symptoms are restricted in daily life
because they have both psychological and somatic symptoms.
What does this paper add?
In the 10 years before the diagnosis of chronic functional
somatic symptoms patients have a great diversity of functional
somatic symptoms. This supports the concept that patients do
not cluster in specific somatic syndromes. Although the
number of visits is twice as frequent, patients with chronic
functional somatic symptoms do not have more somatic self-
limiting or chronic disorders than controls, but the use of
somatic and psychotropic drugs is much higher.
mean age of all patients was 42.0 years (range =
10–85 years). Most subjects were of low (44.5%) or middle
(42.9%) socioeconomic class. 
Functional somatic symptoms
The incidence rate of patients with chronic functional
somatic symptoms was 3.5 per 1000 patient years, where-
as the prevalence of patients known to have chronic func-
tional somatic symptoms is established on 68.8 per 1000
patient years.
The presented functional somatic symptoms in various
body systems in patients and controls is displayed in Table 1.
For each symptom group, patients and controls differ signifi-
cantly (P<0.05). It is remarkable that many patients had
symptoms in various body systems — a finding that is 
supported by the factor analysis (Figure 1) — as it is often
considered that there are a number of well-defined distinct
functional somatic syndromes, clustering around physical
symptoms of one body system. Moreover, factor analysis sug-
gests that, on the one hand, gastrointestinal, cardiorespiratory,
and pseudopsychiatric symptoms are linked and, on the
other, that pseudoneurological symptoms, musculoskeletal
symptoms, and headache and other pain, are linked with
each other. Significantly more patients than controls present-
ed symptoms in two or more body systems (87.9% versus
19.8%; OR = 29.5, 95% CI = 16.0 to 54.9). Of all the patients,
25% presented symptoms in four or more body systems.
Half of the patients had three or more episodes of func-
tional somatic symptoms before he or she was diagnosed as
having chronic functional somatic symptoms; 25% of
patients had five or more episodes before chronic functional
somatic symptoms were diagnosed.
Comorbidity: somatic and psychiatric
Patients with chronic functional somatic symptoms had
significantly more psychiatric disorders in comparison with
controls (OR = 2.4) (Table 2). Patients did not have a much
higher rate of chronic and self-limiting somatic comorbidity,
and they had only slightly more episodes of self-limiting air-
way problems than controls.
Consultations, referrals, diagnostic tests and
hospital admissions
The number of consultations in patients with chronic 
functional somatic symptoms is significantly higher (n =
9.8 versus n = 4.2, P<0.001), as is the number of subjects
referred for diagnostic testing (n = 156 versus n = 140, OR
= 1.8). The number of home visits was equal in both
groups. About three-quarters of patients had been referred
to somatic specialists, compared with about half of the
controls. About one-third of the patients had been referred
to mental health sources compared with less than 10% in
controls. Hospital admissions were the same. These data
are outlined in Table 2.
Medication use
The results regarding medication use are detailed in Table 3.
We found that patients with chronic functional somatic
symptoms used significantly more somatic medications (2.6
versus 1.5, P<0.001) and psychotropic drugs (0.4 versus
0.05, P<0.001) per year compared with controls. The num-
ber of patients using antidepressants and benzodiazepines
is statistically different in both groups (35.6% versus 5.9%;
52.5% versus 12.7% respectively, P<0.001).
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Table 1. Distribution of functional somatic symptoms in the various body systems (n = 182).
Patients (%) Controls (%) Odds ratio (95% CI)a
Pseudoneurological 54 (29.7) 13 (7.1) 5.5 (2.8 to 11.1)
Gastrointestinal 69 (37.9) 15 (8.2) 6.8 (3.6 to 13.1)
Musculoskeletal 58 (31.9) 6 (3.3) 13.7 (5.5 to 36.5)
Cardiorespiratory 74 (40.7) 16 (8.8) 7.1 (3.8 to 13.5)
Headache and other pain 80 (44.0) 15 (8.2) 8.7 (4.6 to 16.6)
Pseudopsychiatric 150 (82.4) 48 (26.4) 13.1 (7.7 to 22.4)
Others 66 (36.3) 10 (5.5) 9.8 (4.6 to 12.2)
Unknown 67 (36.8) 0 (0) -
a Statistically significant difference between patients and controls.
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Figure 1. Symptom diversity in patients with chronic functional
somatic symptoms and their matched controls.
In patients using medication, antidepressants were used
for a mean of 20 days a year and benzodiazepines for
9 days a year compared with 5 and 4 days, respectively, in
controls. However, these findings do not reach statistical sig-
nificance. Moreover, there is no difference in prescribed
daily dose for patients and controls.
Discussion
Strengths and limitations of this study
The strength of the present study is that the patients who
were included were those who consulted their GP, irrespec-
tive of the presented symptoms. Therefore, a threshold of
relevance of the symptoms for the patient was established
and we were able to analyse all symptoms presented. Most
population-based studies assess all symptoms irrespective
of the perceived need for help.10,16,17 Moreover, in popul-
ation-based studies, interviewing patients repeatedly does
not lead to a consistent classification of somatoform disor-
ders,18 whereas our classification of the presented morbidity
is based on very stable data,29,34 in which longitudinal
research is allowed and recall bias will not occur.
The limitations of the study are the retrospective use of
data in existing medical records and the possible interdoctor
variation of the diagnosis of chronic functional somatic
symptoms.35 The interdoctor variation is partly a con-
sequence of not having explicitly stated criteria for chronic
functional somatic symptoms in the CMR. This subjectivity
will possibly always exist because diagnosing chronic
functional somatic symptoms remains an interpretation of
the symptoms, and is influenced by foreknowledge and
context.27 However, it is known from the literature that the
GP’s judgement on somatisation seems valid in daily prac-
tice. Moreover, additional validation of clinical judgement is
possible through longitudinal follow-up.36 The subjectivity
of the diagnosis and the doctor–patient relationship also
make important contributions to the genesis and persis-
tence of functional somatic symptoms.37 The doctor’s
knowledge of the patient’s complaints is an important
issue and is associated with a better outcome.
Of all the variables described, only consultation frequency
is directly linked with the diagnosis of chronic functional
somatic symptoms — as such, the higher frequency of GP
visits was to be expected a priori.38
Summary of main findings
This is the first observational study using longitudinal data
describing patients in whom consulting the GP for func-
tional somatic symptoms has become a regular way of pre-
senting. During the 10 years before a diagnosis of chronic
functional somatic symptoms is established by the GP,
patients consult their GP twice as much, use much more
somatic and psychotropic medication, have more psychi-
atric morbidity and are more often referred to mental health
workers than controls. During these 10 years, the number
of diagnostic tests is slightly higher in patients and the
number of hospital admissions is equal in comparison with
controls. Patients with chronic functional somatic symp-
toms are more likely to present symptoms in two or more
body systems and they present a higher number and
greater diversity of symptoms to the GP than control
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Table 2. Number of consultations, comorbidity, referrals, diagnostic tests, and hospital admissions in patients and controls (n = 182).
Patients Controls P-value Odds ratio (95% CI)
GP consultations in 1 yeara (mean [range])
Practice visits 9.8 (2.5–26.8) 4.2 (0–15.1) <0.001b -
Home visits 0.2 (0–3.5) 0.3 (0–7.1) 0.53 -
Comorbidity (n [%])
Somatic chronic:
Diabetes mellitus 5 (2.7) 4 (2.2) - 1.3 (0.3 to 5.7)
Asthma/COPD 20 (11.0) 10 (5.5) - 2.1 (0.9 to 5.0)
Cardiovascular 16 (8.8) 8 (4.4) - 2.1 (0.8 to 5.5)
Somatic self-limiting
Skin 96 (52.7) 82 (45.1) - 1.4 (0.9 to 2.1)
Musculoskeletal 130 (71.4) 115 (63.2) - 1.5 (0.9 to 2.3)
Airway 136 (74.4) 113 (62.1) - 1.8 (1.1 to 2.9)b
Psychiatricc 41 (22.5) 20 (11.0) - 2.4 (1.3 to 4.4)b
Referrals (n [%])
Somatic: medical 130 (71.4) 97 (53.3) - 2.2 (1.4 to 3.5)b
Somatic: paramedicald 129 (70.9) 87 (47.8) - 2.6 (1.7 to 4.2)b
Mental health 59 (32.4) 15 (8.2) - 5.3 (2.8 to 10.3)b
Diagnostic teste (n [%]) 156 (85.7) 140 (76.9) - 1.8 (1.0 to 3.2)b
Hospital admissions (n [%])
Somatic 57 (31.3) 51 (28.0) - 1.2 (0.7 to 1.9)
Psychiatric 1 (0.5) 1 (0.5) - 1.0
an = 118: one general practice did not use the computerised registration, so consultation could not be established in this practice. bStatistically 
significant difference between patients and controls P<0.05. cIncluding schizophrenia, depression, psychoses, hysteria, phobia, neuroses, 
post-traumatic stress disorder, alcoholism, use of street drugs. dIncluding physiotherapist, dietician. eIncluding haematological tests, x-ray 
examinations, ultrasonography, and electrocardiography.
patients. GPs in this study appear to classify patients as
having chronic functional somatic symptoms after three
episodes of presenting with functional somatic symptoms.
Comparison with the existing literature
The finding that patients could be recognised as having
chronic functional somatic symptoms after they had exp-
erienced three episodes of functional somatic symptoms
presented in two or more body systems, is an important
one. Functional somatic symptoms are often recognised
after having excluded other possible diagnoses. This may
be associated with unnecessary and possibly harmful
diagnostic strategies and may promote somatic fixation.
Early identification of these patients could prevent somatic
fixation, and enables the GP to modify his/her proceed-
ings.39 Additionally, this finding was confirmed using factor
analysis and shows that functional somatic symptoms
probably do not cluster in well defined specific somatic
syndromes. It also suggests that symptom variation is
great in these patients. 
The concept of patients with functional somatic syndromes
presenting symptoms in many body systems has also been
supported by recent studies.20 Therefore, the existence of
specific somatic syndromes should be challenged. With a
broad-based approach, the GP might be the appropriate
practitioner to diagnose and treat these patients by emph-
asising the biomedical as well as the psychosocial factors
involved in symptom production and perception.40
The finding that patients with chronic functional somatic
symptoms did not have a higher rate of chronic and self-
limiting somatic comorbidity is remarkable because it is
stated in the literature that somatisation with more frequent
examination may increase the chance of chronic diseases
being discovered.36 We found that more frequent consulta-
tion did not lead to more diagnosed chronic and self-limit-
ing diseases in patients with chronic functional somatic
symptoms.
The diagnosis of chronic functional somatic symptoms is
not recorded as such in the DSM-IV classification. It no
doubt exists as part of the spectrum somewhere between
somatisation disorder and somatoform disorder not other-
wise specified. The condition resembles the concept of
‘abridged somatisation’,10 but is not based on the number
of symptoms. Both ‘abridged somatisation’ and chronic
functional somatic symptoms presume underlying psycho-
logical distress. The prevalence of somatisation disorder
according to the DSM-IV in primary care is low because of
the stringent criteria.40,41 On the other hand, less severe
forms of somatisation have a major impact on quality of life
and on the use of health services, and are more prevalent. 
Implications for further research and clinical
practice
Patients with chronic functional somatic symptoms may be
considered as persistent complainers and consequently
labelled as ‘difficult’ patients. The condition may indeed
reflect a greater propensity to complain; however, as is
apparent from the excess of psychiatric comorbidity,
patients with chronic functional somatic symptoms also
have more reason to complain. With regard to these
patients, it seems that consulting the GP for functional
somatic symptoms has become a regular way of presenting,
but it might also be that patients who attend more often are
at higher risk of being considered as having chronic func-
tional somatic symptoms. Moreover, the diagnosis might
relate to frustrated doctors as a consequence of lack of
understanding, or failures in the communication between
doctor and patient.
Chronic functional somatic symptoms are a major
cause of morbidity and deserve further investigation to
estimate the importance of the doctor–patient relation-
ship, the feasibility of treatments, and the understanding
of the aetiology of functional symptoms to identify
patients who are likely to become persistent complainers
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Table 3. Medication use in patients and controlsa (n = 118).
Patients Controls P-value Odds ratio (95% CI)
Number of somatic medications per year (mean [range]) 2.6 (0–18.0) 1.5 (0–7.5) <0.001b -
Number of psychotropic drugs per year (mean [range]) 0.4 (0–9.0) 0.05 (0–0.62) <0.001 -
Number of patients using psychotropic drugs (n [%])
Antidepressants 42 (35.6) 7 (5.9) - 7.5 (3.1 to 18.9)
Benzodiazepines 62 (52.5) 15 (12.7) - 5.8 (3.0 to 11.1)
Others 3 (2.5) 3 (2.5) - 1.0
Days of psychotropic drug use per year (median [range])
Antidepressants 19.5 (1.9–297.0)c 5.0 (1.62–91.7)d - -
Benzodiazepines 8.9 (0.4–322.5)c 4.2 (1.1–90.8)d - -
Others 34.3 (1.7–58.2)c 3.8 (0.2–25.1)d - -
Prescribed daily doses (mean [range])
Antidepressants 0.76 (0.20–1.37)c 0.77 (0.13–2.00)d - -
Benzodiazepines 0.62 (0.06–1.50)c 0.61 (0.20–1.54)d - -
Others 0.51 (0.25–0.75)c 0.31 (0.25–0.40)d - -
an = 118: one general practice did not use the computerised registration, so medication could not be established in this practice. bStatistically 
significant difference between patients and controls P<0.05. cFor patients with antidepressants, benzodiazepines and other psychotropic drugs, 
n = 42, 62, and 3, respectively. dFor patients with antidepressants, benzodiazepines and other psychotropic drugs, n = 7, 15, and 3, respectively.
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and develop the behavioural pattern of patients with
chronic functional somatic symptoms. 
Also, the overlap of chronic functional somatic symptoms
with the various DSM-IV diagnoses should be studied. This is
important because the validity of the classification of mental
disorders is useful, but also questionable.42 Thinking in nar-
row syndromes might hinder an appropriate interpretation of
the patient’s syndromes.
Patients repeatedly presenting functional somatic symp-
toms to the GP in two or more body systems, particularly
when combined with psychological complaints, should 
be regarded as candidates for the diagnosis of chronic
functional somatic symptoms. It seems that the presented
functional somatic symptoms are part of a single syndrome
and that symptom variation is great in these patients.
Therefore, the GP, who is considered as being knowledge-
able about underlying psychosocial problems, should 
diagnose, treat, and accompany these patients. 
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